Page last updated: 2024-10-30

meprobamate and Multiple Myeloma

meprobamate has been researched along with Multiple Myeloma in 1 studies

Meprobamate: A carbamate with hypnotic, sedative, and some muscle relaxant properties, although in therapeutic doses reduction of anxiety rather than a direct effect may be responsible for muscle relaxation. Meprobamate has been reported to have anticonvulsant actions against petit mal seizures, but not against grand mal seizures (which may be exacerbated). It is used in the treatment of ANXIETY DISORDERS, and also for the short-term management of INSOMNIA but has largely been superseded by the BENZODIAZEPINES. (From Martindale, The Extra Pharmacopoeia, 30th ed, p603)

Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Doody, MM1
Linet, MS1
Glass, AG1
Curtis, RE1
Pottern, LM1
Rush, BB1
Boice, JD1
Fraumeni, JF1
Friedman, GD1

Other Studies

1 other study available for meprobamate and Multiple Myeloma

ArticleYear
Risks of non-Hodgkin's lymphoma, multiple myeloma, and leukemia associated with common medications.
    Epidemiology (Cambridge, Mass.), 1996, Volume: 7, Issue:2

    Topics: Adult; Aged; Amphetamines; California; Case-Control Studies; Chloramphenicol; Confidence Intervals;

1996